Life Sciences Medical DeviceTewksbury, MA
Corvia Medical, Inc., formerly DC Devices Inc., is a privately held medical device company dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. Heart failure is a major public health concern, particularly in developed countries with aging populations. Although medications and implantable cardiac rhythm devices can help alleviate symptoms in many patients with heart failure, there is currently no effective treatment for the vast majority of patients. The company's first product, the Corvia(R) InterAtrial Shunt Device (IASD(r)), is the world’s first transcatheter device approved in the European Union to treat heart failure with preserved (HFpEF) or mid-range ejection fraction (HFmrEF). After creating a small opening in the atrial septum, the IASD implant is deployed, forming a passage between the left and right atria that enables the left atrium to decompress at rest and physical activity, with the aim of lowering left atrial pressure. By facilitating continuous and dynamic decompression of the left atrium, the IASD aims to improve heart failure symptoms and quality of life, decrease heart failure hospitalization rates, and reduce the overall cost burden of managing heart failure patients. For more information, please visit www.corviamedical.com. The IASD is not available for commercial distribution in the United States.